Drug Development

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

February 22, 2018

Agreement follows the recent opening of WuXi STA’s oligonucleotide R&D labs in China and the USA SHANGHAI, 22 Feb 2018: STA Pharmaceutical Co., Ltd. (STA), a WuXi AppTec group company and the leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing, and Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery […]

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing with Quality and Consistency While Crossing One Million Case Milestone in 2017

February 22, 2018

Quality and value in Bioclinica ICSR outsourcing enable drug safety operations to meet global regulatory requirements for safety monitoring of medicines PRINCETON, NJ– Bioclinica®, the world-leading provider of scientific- and technology-enabled solutions for clinical research, today announces its ICSR team delivered quality and consistency in Individual Case Safety Report (ICSR) processing while crossing the one […]

Proteomics International announces Strategic Alliance and Investment in CPR Pharma Services

February 15, 2018

PERTH, W. AUS.,  Feb 16, 2018 – MedTech pioneer Proteomics International (PILL; ASX: PIQ) has entered into a strategic alliance with CPR Pharma Services (CPR), targeting the high growth area of clinical trials and related research, with an offer to acquire 10% of CPR’s share capital through the issue of 4 million PIQ shares. This alliance […]

Recipharm appoints President Development Services to drive end to end offering

February 14, 2018

Contract development and manufacturing organisation (CDMO) Recipharm has appointed Bernard Pluta to lead its new global development organisation. The newly established position forms part of the ongoing transformation of Recipharm’s Development Services, in which a total of 400 employees across six countries are united to deliver a comprehensive development offering. The scientific, chemical and pharmaceutical expertise will cover […]

Wout Brusselaers to Speak at HIMSS18 on Finding the Return on Investment of Artificial Intelligence

February 14, 2018

HIMSS has named Wout Brusselaers, chief executive officer of Deep 6 AI , an artificial intelligence (AI) company focused on accelerating patient recruitment for clinical trials, as a speaker for the 2018 HIMSS Conference & Exhibition (HIMSS18). Brusselaers will co-present the “Finding the ROI of AI” educational session with Bobbie J. Rimel, MD, gynecologic oncologist and associate director for gynecological […]

ADC Bio developing downstream bioconjugation process

February 12, 2018

New manufacturing paradigm will save 25% of total costs and Specialist Process Innovation Group created to validate approach 12 February 2018, Wales:ADC Biotechnology (ADC Bio) announces that it is developing a revolutionary, ‘downstream bioconjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing. In contrast to the existing approaches – which […]

FEEDBACK